Breast Cancer: Molecular Pathology, Drug Resistance and Novel Treatment Strategies
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 906
Special Issue Editor
Interests: breast cancer; mechanism of drug resistance; novel therapeutic targets; precision oncology; novel treatment strategies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Breast cancer is a highly heterogeneous disease, and despite significant therapeutic advancements, resistance to therapies and recurrence remain major clinical challenges. Understanding the molecular pathology of breast cancer is crucial for identifying mechanisms that drive drug resistance and disease progression. Emerging targeted therapies, immunotherapies, and novel drug combinations offer new hope, but their effectiveness is often limited by tumor heterogeneity and the complexity of the tumor microenvironment. This Special Issue will focus on the latest insights into breast cancer biology, explore mechanisms of resistance to current therapies, and highlight innovative treatment strategies aimed at improving patient outcomes.
Dr. Yesim Gokmen-Polar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- mechanism of resistance
- targeted therapy resistance
- ER+
- HER2
- TNBC
- tumor microenvironment
- recurrence
- metastasis
- tumor evasion
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
